Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KHC vs MRNA✓SelectedUSD · MRNAKHC vs MRNA performance historyLatest closeAs of+1.31%11/18
Stock and ETF performance explorer

KHC vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-22.8%
MRNA return
+794.5%
Excess return
-817.3%
Maximum drawdown
-55.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+1.3%-4.8%+6.2%+1.4%
7D+4.8%-20.9%+25.7%+5.3%
30D+9.8%-13.3%+23.1%+10.0%
3M+4.1%+212.6%-208.4%-0.5%
6M+12.7%+309.0%-296.3%+6.8%
YTD+10.3%+567.3%-557.0%+2.8%
1Y+8.9%+689.7%-680.8%+0.8%
3Y-10.7%+157.4%-168.1%-15.8%
5Y-7.4%-21.7%+14.3%-11.5%
All-22.8%+794.5%-817.3%-33.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling